Financial Instruments | Financial Instruments Derivatives Our primary market exposure is to interest rate risk, specifically U.S. treasury and mortgage interest rates, due to their impact on mortgage-related assets and commitments. We use forward sales commitments on whole loans and mortgage-backed securities to manage and reduce this risk. We do not have any derivative instruments designated as hedging instruments. Forward Sales Commitments —We are exposed to interest rate and price risk on loans held for sale from the funding date until the date the loan is sold. Forward sales commitments on whole loans and mortgage-backed securities are used to fix the forward sales price that will be realized at the sale of each loan. Interest Rate Lock Commitments —Interest rate lock commitments ("IRLCs") represent an agreement to extend credit to a mortgage loan applicant. We commit (subject to loan approval) to fund the loan at the specified rate, regardless of changes in market interest rates between the commitment date and the funding date. Outstanding IRLCs are subject to interest rate risk and related price risk during the period from the date of commitment through the loan funding date or expiration date. Loan commitments generally range between 30 and 90 days and the borrower is not obligated to obtain the loan. Therefore, IRLCs are subject to fallout risk, which occurs when approved borrowers choose not to close on the underlying loans. We review our commitment-to-closing ratio ("pull-through rate") as part of an estimate of the number of mortgage loans that will fund according to the IRLCs. Notional Amounts September 30, 2021 December 31, 2020 Forward sales commitments $ 96,397 $ 130,109 IRLCs 94,301 88,923 The locations and amounts of gains (losses) recognized in income related to our derivatives are as follows: Three Months Ended September 30, Nine Months Ended September 30, Instrument Classification 2021 2020 2021 2020 Forward sales commitments Service revenue $ 859 $ 553 $ 938 $ 442 IRLCs Service revenue (888) (233) (687) 1,131 Fair Value of Financial Instruments In May 2020, we purchased preferred stock of Matterport, Inc. ("Matterport"), then a privately held company. In July 2021, Matterport became a publicly traded company through a business combination transaction with a special purpose acquisition vehicle. In connection with the transaction, we received Matterport's publicly traded Class A common stock in exchange for the preferred stock that we owned. We previously recorded our investment at cost because the preferred stock did not have a readily determinable fair value, but upon receipt of the publicly traded common stock, we recorded our investment at fair value. The increase in value is recorded in other income (expense), net in our consolidated statements of comprehensive (loss) income for the three and nine months ended September 30, 2021, and is included in adjustments to reconcile net loss to net cash used in operating activities, as a component of other, in our consolidated statement of cash flows for the nine months ended September 30, 2021. The balance is included in short-term investments in our consolidated balance sheets. A summary of assets and liabilities related to our financial instruments, measured at fair value on a recurring basis and as reflected in our consolidated balance sheets, is set forth below: Balance at September 30, 2021 Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Assets Cash equivalents Money market funds $ 501,432 $ 501,432 $ — $ — Total cash equivalents 501,432 501,432 — — Short-term investments U.S. treasury securities 11,981 11,981 — — Agency bonds 11,912 11,912 — — Equity securities 4,685 4,685 — — Loans held for sale 42,762 — 42,762 — Other current assets Forward sales commitments 552 — 552 — IRLCs 1,146 — — 1,146 Total other current assets 1,698 — 552 1,146 Long-term investments U.S. treasury securities 53,488 53,488 — — Total assets $ 627,958 $ 583,498 $ 43,314 $ 1,146 Liabilities Accrued liabilities Forward sales commitments $ 87 $ — $ 87 $ — IRLCs 62 — — 62 Total liabilities $ 149 $ — $ 87 $ 62 Balance at December 31, 2020 Quoted Prices in Active Markets for Identical Assets Significant Significant Assets Cash equivalents Money market funds $ 886,261 $ 886,261 $ — $ — U.S. treasury securities 6,100 6,100 — — Total cash equivalents 892,361 892,361 — — Short-term investments U.S. treasury securities 131,561 131,561 — — Loans held for sale 42,539 — 42,539 — Other current assets Forward sales commitments 34 — 34 — IRLCs 1,781 — — 1,781 Total other current assets 1,815 — 34 1,781 Long-term investments Agency bonds 11,922 11,922 — — Total assets $ 1,080,198 $ 1,035,844 $ 42,573 $ 1,781 Liabilities Accrued liabilities Forward sales commitments $ 507 $ — $ 507 $ — IRLCs 10 — — 10 Total liabilities $ 517 $ — $ 507 $ 10 There were no transfers into or out of Level 3 financial instruments during the periods presented. The significant unobservable input used in the fair value measurement of IRLCs is the pull-through rate. Significant changes in the input could result in a significant change in fair value measurement. The pull-through rate used to determine the fair value of IRLCs was as follows: Key Inputs Valuation Technique September 30, 2021 December 31, 2020 Weighted-average pull-through rate Market pricing 71.7% 72.3% The following is a summary of changes in the fair value of IRLCs for the nine months ended September 30, 2021: Balance, net—January 1, 2021 $ 1,771 Issuances of IRLCs 14,523 Settlements of IRLCs (14,956) Net loss recognized in earnings (254) Balance, net—September 30, 2021 $ 1,084 Changes in fair value recognized during the period relating to assets still held at September 30, 2021 $ (687) The following table presents the carrying amounts and estimated fair values of our convertible senior notes that are not recorded at fair value on our consolidated balance sheets: September 30, 2021 December 31, 2020 Issuance Net Carrying Amount Estimated Fair Value Net Carrying Amount Estimated Fair Value 2023 notes $ 23,243 $ 38,980 $ 22,482 $ 59,894 2025 notes 650,093 660,556 488,268 802,083 2027 notes 562,674 516,856 — — The difference between the principal amounts of our 2023 notes, our 2025 notes, and our 2027 notes, which were $23,512, $661,250, and $575,000, respectively, and the net carrying amounts of the notes represents the unamortized debt issuance costs. See Note 16 for additional details. The estimated fair value of each tranche of convertible senior notes is based on the closing trading price of the notes on the last day of trading for the period, and is classified as Level 2 within the fair value hierarchy, due to the limited trading activity of the notes. As of September 30, 2021, the difference between the net carrying amount of the notes and their estimated fair values represented the notes' equity conversion premium. Based on the closing price of our common stock of $50.10 on September 30, 2021, the if-converted value of the 2023 notes exceeded the principal amount of $23,512, while the if-converted values of the 2025 notes and 2027 notes were less than the principal amounts of $661,250 and $575,000, respectively. See Note 16 for additional details on our convertible senior notes. See Note 12 for the carrying amount of our convertible preferred stock. Assets and liabilities recognized or disclosed at fair value on a nonrecurring basis include items such as property and equipment, goodwill and other intangible assets, and other assets. These assets are remeasured at fair value if determined to be impaired. The cost or amortized cost, gross unrealized gains and losses, and estimated fair market value of our cash, money market funds, restricted cash, available-for-sale investments, and equity securities were as follows: September 30, 2021 Cost or Amortized Cost Unrealized Gains Unrealized Losses Estimated Fair Value Cash, Cash Equivalents, Restricted Cash Short-term Investments Long-term Investments Cash $ 61,282 $ — $ — $ 61,282 $ 61,282 $ — $ — Money markets funds 501,432 — — 501,432 501,432 — — Restricted cash 74,532 — — 74,532 74,532 — — U.S. treasury securities 65,461 16 (8) 65,469 — 11,981 53,488 Agency bonds 11,900 12 — 11,912 — 11,912 — Equity securities 500 4,185 — 4,685 — 4,685 — Total $ 715,107 $ 4,213 $ (8) $ 719,312 $ 637,246 $ 28,578 $ 53,488 December 31, 2020 Cost or Amortized Cost Unrealized Gains Unrealized Losses Estimated Fair Value Cash, Cash Equivalents, Restricted Cash Short-term Investments Long-term Investments Cash $ 32,915 $ — $ — $ 32,915 $ 32,915 $ — $ — Money markets funds 886,261 — — 886,261 886,261 — — Restricted cash 20,544 — — 20,544 20,544 — — U.S. treasury securities 137,502 159 — 137,661 6,100 131,561 — Agency bonds 11,900 22 — 11,922 — — 11,922 Total $ 1,089,122 $ 181 $ — $ 1,089,303 $ 945,820 $ 131,561 $ 11,922 We have evaluated our portfolio of available-for-sale debt securities based on credit quality indicators for expected credit losses and do not believe there are any expected credit losses. Our portfolio consists of U.S. government securities, all with a high quality credit rating issued by various credit agencies. As of September 30, 2021 and December 31, 2020, we had accrued interest of $148 and $108, respectively, on our available-for-sale investments, of which we have recorded no expected credit losses. Accrued interest receivable is presented within other current assets in our consolidated balance sheets. |